Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials
Eur Heart J Cardiovasc Pharmacother
.
2023 Jun 2;9(4):299-300.
doi: 10.1093/ehjcvp/pvad002.
Authors
Anthony E Peters
1
2
,
Robert J Mentz
1
2
,
Stephen J Greene
1
2
Affiliations
1
Division of Cardiology, Duke University School of Medicine, 27701 Durham, NC USA.
2
Duke Clinical Research Institute, 27701 Durham, NC USA.
PMID:
36639123
PMCID:
PMC10236509
DOI:
10.1093/ehjcvp/pvad002
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Diuretics / adverse effects
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Substances
Diuretics
Grants and funding
T32 HL069749/HL/NHLBI NIH HHS/United States